Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on June 11, 2009

Stroke. 2009
Published online before print June 11, 2009, doi: 10.1161/STROKEAHA.109.549691
A more recent version of this article appeared on September 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/9/3107    most recent
STROKEAHA.109.549691v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jin, Y.
Right arrow Articles by Vannucci, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, Y.
Right arrow Articles by Vannucci, S. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CROMOLYN
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Other Stroke Treatment - Medical

Submitted on March 5, 2009
Revised on May 4, 2009
Accepted on May 8, 2009

Mast Cells Are Early Responders After Hypoxia-Ischemia in Immature Rat Brain

Yuxuan Jin MD, PhD; Ann J. Silverman PhD; and Susan J. Vannucci PhD*

From the Weill Cornell Medical College (S.J.V.), New York; and the Department of Pathology and Cell Biology (Y.J., A.J.S.), Columbia University Medical Center, New York, NY.

* To whom correspondence should be addressed. E-mail: suv2003{at}med.cornell.edu.

Background and Purpose—Perinatal hypoxia-ischemia (HI) produces acute and prolonged inflammation of the brain. Mast cells (MCs), numerous in the pia and CNS of neonatal rats, can initiate inflammation attributable to preformed mediators. MCs contribute to HI brain damage in the neonatal rat; MC stabilization protects through 48 hours of reperfusion. Here we hypothesize that HI induces early MC migration, activation, and release of proinflammatory molecules.

Methods—HI was induced by right CCA ligation and 75 minutes 8% oxygen. Histochemistry and immunocytochemistry described the time course of early cellular changes in the CNS. For neuroprotection by MC stabilization, pups were treated with Cromolyn (CR) during the initial 24 hours post-HI; brains were examined through 4 weeks.

Results—Brain MC number and activation were elevated in ipsilateral hemisphere immediately after HI (P<0.05), before detection of cleaved caspase-3 in neurons (NeuN+; 2 hours post-HI), astroglial activation (GFAP+ with swollen cell body, 4 hours post-HI), or microglial activation (OX42+, 4 hours post-HI). TNF-{alpha}–positive MCs were present in a subpopulation of MCs in control animals and the percent of TNF-{alpha} MCs increased dramatically ipsilaterally immediately after HI (P<0.01). Microglial TNF-{alpha} was evident at 4 hours; endothelial cells had no detectable TNF-{alpha} until 48 hours post-HI. Cromolyn prevented MC migration, reduced brain damage/neuronal loss, glial activation, and brain atrophy through 4 weeks of recovery (P<0.05).

Conclusions—MCs are early responders to HI in neonatal brain. MC stabilization provides lasting protection and suggests a new target for therapeutic interventions.


Key words: TNF-{alpha} • Cromolyn • inflammation • neuroprotection